MICONAL*15 VAGINAL OVULES 50MG

MICONAL
2% dermatological cream
2% dermatological powder
2% vaginal cream
50 mg vaginal suppositories
1200 mg vaginal capsules
0.2% vaginal wash

What it is and what it is used for
2% dermatological cream and 2% dermatological powder
Local treatment of skin and nail infections caused by dermatophytes or Candida.
2% vaginal cream, 50 mg vaginal suppositories, 1200 mg vaginal capsules, 0.2% vaginal wash
Treatment of vaginal or vulvovaginal fungal infections, particularly those caused by Candida.

What you need to know before taking the medicine
Confirmed individual hypersensitivity to the product or to other chemically related compounds.

Warnings and precautions
Consult your doctor or pharmacist before using Miconal.
If sensitization or irritation occurs, especially with prolonged use, discontinue treatment and contact your doctor.
Wash your hands thoroughly after each application, unless the treatment involves the hands themselves.
It is advisable to apply the following hygiene measures to avoid sources of infection or reinfection (new infections by the same fungus):
• Use your own towels and underwear to avoid infecting other people;
• Change your underwear regularly to avoid reinfection.
Your sexual partner may also need treatment if they have been infected. If in doubt, consult your doctor.
If sensitization or an allergic reaction occurs, treatment must be discontinued.

Prolonged use of the drug may lead to sensitization phenomena.
In such a case, it is necessary to discontinue treatment and initiate appropriate therapy.
Miconal dermatological or vaginal cream contains benzoic acid
Benzoic acid can be slightly irritating to the skin, eyes, and mucous membranes.
Miconal dermatological or vaginal cream contains butylated hydroxyanisole
Butylated hydroxyanisole can cause local skin reactions (e.g., contact dermatitis) or irritation of the eyes and mucous membranes.
Miconal vaginal wash contains propylene glycol
Propylene glycol can cause skin irritation.

Possible side effects
Side effects with unknown frequency (frequency cannot be estimated from the available data):
• Allergy, including severe allergic reaction that appears quickly (anaphylactic and anaphylactoid reaction)
• Swelling of the face, mouth, lips and/or tongue (angioedema)
• Itching
• Skin rash (urticaria; rash)
• Contact dermatitis (skin inflammation)
• Erythema
• Burning sensation of the skin
• Reactions at the application site
• Vaginal irritation and burning (vaginal formulations)
• Pelvic cramps (vaginal formulations)
• Headache (vaginal formulations)

Reporting of side effects
If you experience any side effects, including those not listed in this leaflet, talk to your doctor or pharmacist. You can also report side effects directly via the national reporting system at: https://www.aifa.gov.it/content/segnalazionireazioni-avverse.
By reporting side effects, you can help provide more information on the safety of this medicine.